36C26122Q0643 Line Items (1).xlsx
XLSX spreadsheet 452 KB Posted
- Solicitation number
- 662-23-1-061-0001
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Action Line Item Information
| Action Type Name | Primary ID | Secondary ID | Mod Number | Title | Order Discount Type Name | Order Discount Type | Order Discount |
| RFQ | 36C26122Q0643 | 5-Year Contract for Blood Products | Percent | 0 |
KB Version: FY22.08A
Items
| Item Number | SLIN | Description | Ref CLIN | Comment | Include Comments in Document | Contract Period | Pop Begin | Pop End | Quantity | Unit of Measure | Packaging Multiple | Receipt Type | Line Item Is | Unit Price | Item Discount Type Name | Item Discount | Date Updated | Address1 | Address2 | Address3 | City | State | Zip | Zip4 | Country | Mark For | Contact Name | Contact Phone | Contact Email | Delivery Date | FOB | Special Instructions | Include Instructions/Comments in Document | PRINCIPAL NAICS CODE | PRODUCT/SERVICE CODE | UNSPSC | SIC CODE | MANUFACTURER PART NUMBER (MPN) | NATIONAL STOCK NUMBER | LOCAL STOCK NUMBER | DM DOC ID | DELIVERY REF. COUNTER | UNIT TEXT/DESCRIPTION | DELIVERY REFERENCE | ITEM MASTER FILE NUMBER | EXPENDABLE/NON-EXPENDABLE | QUANTITY REQUESTED | UNIT OF PURCHASE CODE | UNIT OF PURCHASE TEXT/DESC. |
| 0001 | Leukoc-poor RBC | Leukoc-poor RBC | No | Base | 10/1/22 | 9/30/23 | 1400 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 1400 | EA | EACH | ||||||||||||||||||||||||
| 0002 | STAT off hours surcharge | STAT off hours surcharge | No | Base | 10/1/22 | 9/30/23 | 40 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 40 | EA | EACH | ||||||||||||||||||||||||
| 0003 | Red Cells, Irradiated | Red Cells, Irradiated | No | Base | 10/1/22 | 9/30/23 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 100 | EA | EACH | ||||||||||||||||||||||||
| 0004 | Red Cells, Autologous | Red Cells, Autologous | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0005 | Red Cells, Thawed | Red Cells, Thawed | No | Base | 10/1/22 | 9/30/23 | 6 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 6 | EA | EACH | ||||||||||||||||||||||||
| 0006 | Red Cells, Directed | Red Cells, Directed | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0007 | Fresh Frozen Plasma | Fresh Frozen Plasma | No | Base | 10/1/22 | 9/30/23 | 300 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 300 | EA | EACH | ||||||||||||||||||||||||
| 0008 | Platelet, LVDS | Platelet, LVDS | No | Base | 10/1/22 | 9/30/23 | 405 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 405 | EA | EACH | ||||||||||||||||||||||||
| 0009 | PLATELET, PRT | PLATELET, PRT | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0010 | Pooled Cryo | Pooled Cryo | No | Base | 10/1/22 | 9/30/23 | 70 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 70 | EA | EACH | ||||||||||||||||||||||||
| 0011 | RhIg | RhIg | No | Base | 10/1/22 | 9/30/23 | 2 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 2 | EA | EACH | ||||||||||||||||||||||||
| 0012 | Screening for negative blood per antigen | Screening for negative blood per antigen | No | Base | 10/1/22 | 9/30/23 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 100 | EA | EACH | ||||||||||||||||||||||||
| 0013 | IRRADIATE UNITS | IRRADIATE UNITS | No | Base | 10/1/22 | 9/30/23 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 100 | EA | EACH | ||||||||||||||||||||||||
| 0014 | SCREENING FOR CMV NEGATIVE BLOOD | SCREENING FOR CMV NEGATIVE BLOOD | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 0015 | Antibody Identification | Antibody Identification | No | Base | 10/1/22 | 9/30/23 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 25 | EA | EACH | ||||||||||||||||||||||||
| 0016 | Enzyme Panel | Enzyme Panel | No | Base | 10/1/22 | 9/30/23 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 20 | EA | EACH | ||||||||||||||||||||||||
| 0017 | Select Cell Panel | Select Cell Panel | No | Base | 10/1/22 | 9/30/23 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 20 | EA | EACH | ||||||||||||||||||||||||
| 0018 | Absorption/Elution with Panel | Absorption/Elution with Panel | No | Base | 10/1/22 | 9/30/23 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 15 | EA | EACH | ||||||||||||||||||||||||
| 0019 | Inhibition/Panel | Inhibition/Panel | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0020 | Chloroquine Treatment | Chloroquine Treatment | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0021 | Extended Phenotyping | Extended Phenotyping | No | Base | 10/1/22 | 9/30/23 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 25 | EA | EACH | ||||||||||||||||||||||||
| 0022 | Phenotyping, Whole Blood or Red Cell Mass | Phenotyping, Whole Blood or Red Cell Mass | No | Base | 10/1/22 | 9/30/23 | 28 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 28 | EA | EACH | ||||||||||||||||||||||||
| 0023 | Plateletpheresis, crossmatched (unit) | Plateletpheresis, crossmatched (unit) | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 0024 | Screening for historically antigen Negative blood per antigen | Screening for historically antigen Negative blood per antigen | No | Base | 10/1/22 | 9/30/23 | 180 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 180 | EA | EACH | ||||||||||||||||||||||||
| 0025 | Crossmatched Platelet Donor Recruitment | Crossmatched Platelet Donor Recruitment | No | Base | 10/1/22 | 9/30/23 | 30 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 30 | EA | EACH | ||||||||||||||||||||||||
| 0026 | Transportation charge for STAT orders | Transportation charge for STAT orders | No | Base | 10/1/22 | 9/30/23 | 200 | EA | 1 | Quantity | N/C | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 200 | EA | EACH | ||||||||||||||||||||||||
| 0027 | Red cells, Washed | Red cells, Washed | No | Base | 10/1/22 | 9/30/23 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 15 | EA | EACH | ||||||||||||||||||||||||
| 0028 | Volume-reduced cellular products | Volume-reduced cellular products | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 0029 | DTT (Dithiothreitol) screen | DTT (Dithiothreitol) screen | No | Base | 10/1/22 | 9/30/23 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 25 | EA | EACH | ||||||||||||||||||||||||
| 0030 | DTT (Dithiothreitol) panel | DTT (Dithiothreitol) panel | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 0031 | RBC Genotype (HEA BeadChip Assay or similar) | RBC Genotype (HEA BeadChip Assay or similar) | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0032 | Drug study | Drug study | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0033 | Direct Antiglobulin Test | Direct Antiglobulin Test | No | Base | 10/1/22 | 9/30/23 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 25 | EA | EACH | ||||||||||||||||||||||||
| 0034 | Adsorption Auto | Adsorption Auto | No | Base | 10/1/22 | 9/30/23 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 15 | EA | EACH | ||||||||||||||||||||||||
| 0035 | Adsorption Allo | Adsorption Allo | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 0036 | Adsorption REST (cold auto) | Adsorption REST (cold auto) | No | Base | 10/1/22 | 9/30/23 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 1 | EA | EACH | ||||||||||||||||||||||||
| 0037 | ABO/Rh grouping | ABO/Rh grouping | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0038 | Antibody Screen | Antibody Screen | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0039 | PLT Crossmatch (test) | PLT Crossmatch (test) | No | Base | 10/1/22 | 9/30/23 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 15 | EA | EACH | ||||||||||||||||||||||||
| 0040 | Plateletpheresis, HLA matched | Plateletpheresis, HLA matched | No | Base | 10/1/22 | 9/30/23 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 5 | EA | EACH | ||||||||||||||||||||||||
| 0041 | PLT Antibody screen | PLT Antibody screen | No | Base | 10/1/22 | 9/30/23 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 8 | EA | EACH | ||||||||||||||||||||||||
| 0042 | HLA Antibody screen | HLA Antibody screen | No | Base | 10/1/22 | 9/30/23 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 8 | EA | EACH | ||||||||||||||||||||||||
| 0043 | Patient HLA (A,B) typing for HLA PLT selection | Patient HLA (A,B) typing for HLA PLT selection | No | Base | 10/1/22 | 9/30/23 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 8 | EA | EACH | ||||||||||||||||||||||||
| 0044 | HPA-1a Antigen screen | HPA-1a Antigen screen | No | Base | 10/1/22 | 9/30/23 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 1 | EA | EACH | ||||||||||||||||||||||||
| 0045 | Molecular genotype (HPA) | Molecular genotype (HPA) | No | Base | 10/1/22 | 9/30/23 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 1 | EA | EACH | ||||||||||||||||||||||||
| 0046 | SARS-CoV-2 Convalescent Plasma | SARS-CoV-2 Convalescent Plasma | No | Base | 10/1/22 | 9/30/23 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | NONE | No | 621991 | 6505 | N/A | 0 | 0 | E | 10 | EA | EACH | ||||||||||||||||||||||||
| 1001 | Leukoc-poor RBC | Leukoc-poor RBC | Option 1 | 10/01/23 | 09/30/24 | 1400 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1400 | EA | EACH | ||||||||||||||||||||||||||||||
| 1002 | STAT off hours surcharge | STAT off hours surcharge | Option 1 | 10/01/23 | 09/30/24 | 40 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 40 | EA | EACH | ||||||||||||||||||||||||||||||
| 1003 | Red Cells, Irradiated | Red Cells, Irradiated | Option 1 | 10/01/23 | 09/30/24 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 1004 | Red Cells, Autologous | Red Cells, Autologous | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1005 | Red Cells, Thawed | Red Cells, Thawed | Option 1 | 10/01/23 | 09/30/24 | 6 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 6 | EA | EACH | ||||||||||||||||||||||||||||||
| 1006 | Red Cells, Directed | Red Cells, Directed | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1007 | Fresh Frozen Plasma | Fresh Frozen Plasma | Option 1 | 10/01/23 | 09/30/24 | 300 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 300 | EA | EACH | ||||||||||||||||||||||||||||||
| 1008 | Platelet, LVDS | Platelet, LVDS | Option 1 | 10/01/23 | 09/30/24 | 405 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 405 | EA | EACH | ||||||||||||||||||||||||||||||
| 1009 | PLATELET, PRT | PLATELET, PRT | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1010 | Pooled Cryo | Pooled Cryo | Option 1 | 10/01/23 | 09/30/24 | 70 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 70 | EA | EACH | ||||||||||||||||||||||||||||||
| 1011 | RhIg | RhIg | Option 1 | 10/01/23 | 09/30/24 | 2 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 2 | EA | EACH | ||||||||||||||||||||||||||||||
| 1012 | Screening for negative blood per antigen | Screening for negative blood per antigen | Option 1 | 10/01/23 | 09/30/24 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 1013 | IRRADIATE UNITS | IRRADIATE UNITS | Option 1 | 10/01/23 | 09/30/24 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 1014 | SCREENING FOR CMV NEGATIVE BLOOD | SCREENING FOR CMV NEGATIVE BLOOD | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 1015 | Antibody Identification | Antibody Identification | Option 1 | 10/01/23 | 09/30/24 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 1016 | Enzyme Panel | Enzyme Panel | Option 1 | 10/01/23 | 09/30/24 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 1017 | Select Cell Panel | Select Cell Panel | Option 1 | 10/01/23 | 09/30/24 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 1018 | Absorption/Elution with Panel | Absorption/Elution with Panel | Option 1 | 10/01/23 | 09/30/24 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 1019 | Inhibition/Panel | Inhibition/Panel | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1020 | Chloroquine Treatment | Chloroquine Treatment | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1021 | Extended Phenotyping | Extended Phenotyping | Option 1 | 10/01/23 | 09/30/24 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 1022 | Phenotyping, Whole Blood or Red Cell Mass | Phenotyping, Whole Blood or Red Cell Mass | Option 1 | 10/01/23 | 09/30/24 | 28 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 28 | EA | EACH | ||||||||||||||||||||||||||||||
| 1023 | Plateletpheresis, crossmatched (unit) | Plateletpheresis, crossmatched (unit) | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 1024 | Screening for historically antigen Negative blood per antigen | Screening for historically antigen Negative blood per antigen | Option 1 | 10/01/23 | 09/30/24 | 180 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 180 | EA | EACH | ||||||||||||||||||||||||||||||
| 1025 | Crossmatched Platelet Donor Recruitment | Crossmatched Platelet Donor Recruitment | Option 1 | 10/01/23 | 09/30/24 | 30 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 30 | EA | EACH | ||||||||||||||||||||||||||||||
| 1026 | Transportation charge for STAT orders | Transportation charge for STAT orders | Option 1 | 10/01/23 | 09/30/24 | 200 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 200 | EA | EACH | ||||||||||||||||||||||||||||||
| 1027 | Red cells, Washed | Red cells, Washed | Option 1 | 10/01/23 | 09/30/24 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 1028 | Volume-reduced cellular products | Volume-reduced cellular products | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 1029 | DTT (Dithiothreitol) screen | DTT (Dithiothreitol) screen | Option 1 | 10/01/23 | 09/30/24 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 1030 | DTT (Dithiothreitol) panel | DTT (Dithiothreitol) panel | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 1031 | RBC Genotype (HEA BeadChip Assay or similar) | RBC Genotype (HEA BeadChip Assay or similar) | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1032 | Drug study | Drug study | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1033 | Direct Antiglobulin Test | Direct Antiglobulin Test | Option 1 | 10/01/23 | 09/30/24 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 1034 | Adsorption Auto | Adsorption Auto | Option 1 | 10/01/23 | 09/30/24 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 1035 | Adsorption Allo | Adsorption Allo | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 1036 | Adsorption REST (cold auto) | Adsorption REST (cold auto) | Option 1 | 10/01/23 | 09/30/24 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 1037 | ABO/Rh grouping | ABO/Rh grouping | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1038 | Antibody Screen | Antibody Screen | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1039 | PLT Crossmatch (test) | PLT Crossmatch (test) | Option 1 | 10/01/23 | 09/30/24 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 1040 | Plateletpheresis, HLA matched | Plateletpheresis, HLA matched | Option 1 | 10/01/23 | 09/30/24 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 1041 | PLT Antibody screen | PLT Antibody screen | Option 1 | 10/01/23 | 09/30/24 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 1042 | HLA Antibody screen | HLA Antibody screen | Option 1 | 10/01/23 | 09/30/24 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 1043 | Patient HLA (A,B) typing for HLA PLT selection | Patient HLA (A,B) typing for HLA PLT selection | Option 1 | 10/01/23 | 09/30/24 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 1044 | HPA-1a Antigen screen | HPA-1a Antigen screen | Option 1 | 10/01/23 | 09/30/24 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 1045 | Molecular genotype (HPA) | Molecular genotype (HPA) | Option 1 | 10/01/23 | 09/30/24 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 1046 | SARS-CoV-2 Convalescent Plasma | SARS-CoV-2 Convalescent Plasma | Option 1 | 10/01/23 | 09/30/24 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2001 | Leukoc-poor RBC | Leukoc-poor RBC | Option 2 | 10/01/24 | 09/30/25 | 1400 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1400 | EA | EACH | ||||||||||||||||||||||||||||||
| 2002 | STAT off hours surcharge | STAT off hours surcharge | Option 2 | 10/01/24 | 09/30/25 | 40 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 40 | EA | EACH | ||||||||||||||||||||||||||||||
| 2003 | Red Cells, Irradiated | Red Cells, Irradiated | Option 2 | 10/01/24 | 09/30/25 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 2004 | Red Cells, Autologous | Red Cells, Autologous | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2005 | Red Cells, Thawed | Red Cells, Thawed | Option 2 | 10/01/24 | 09/30/25 | 6 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 6 | EA | EACH | ||||||||||||||||||||||||||||||
| 2006 | Red Cells, Directed | Red Cells, Directed | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2007 | Fresh Frozen Plasma | Fresh Frozen Plasma | Option 2 | 10/01/24 | 09/30/25 | 300 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 300 | EA | EACH | ||||||||||||||||||||||||||||||
| 2008 | Platelet, LVDS | Platelet, LVDS | Option 2 | 10/01/24 | 09/30/25 | 405 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 405 | EA | EACH | ||||||||||||||||||||||||||||||
| 2009 | PLATELET, PRT | PLATELET, PRT | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2010 | Pooled Cryo | Pooled Cryo | Option 2 | 10/01/24 | 09/30/25 | 70 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 70 | EA | EACH | ||||||||||||||||||||||||||||||
| 2011 | RhIg | RhIg | Option 2 | 10/01/24 | 09/30/25 | 2 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 2 | EA | EACH | ||||||||||||||||||||||||||||||
| 2012 | Screening for negative blood per antigen | Screening for negative blood per antigen | Option 2 | 10/01/24 | 09/30/25 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 2013 | IRRADIATE UNITS | IRRADIATE UNITS | Option 2 | 10/01/24 | 09/30/25 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 2014 | SCREENING FOR CMV NEGATIVE BLOOD | SCREENING FOR CMV NEGATIVE BLOOD | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2015 | Antibody Identification | Antibody Identification | Option 2 | 10/01/24 | 09/30/25 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 2016 | Enzyme Panel | Enzyme Panel | Option 2 | 10/01/24 | 09/30/25 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 2017 | Select Cell Panel | Select Cell Panel | Option 2 | 10/01/24 | 09/30/25 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 2018 | Absorption/Elution with Panel | Absorption/Elution with Panel | Option 2 | 10/01/24 | 09/30/25 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 2019 | Inhibition/Panel | Inhibition/Panel | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2020 | Chloroquine Treatment | Chloroquine Treatment | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2021 | Extended Phenotyping | Extended Phenotyping | Option 2 | 10/01/24 | 09/30/25 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 2022 | Phenotyping, Whole Blood or Red Cell Mass | Phenotyping, Whole Blood or Red Cell Mass | Option 2 | 10/01/24 | 09/30/25 | 28 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 28 | EA | EACH | ||||||||||||||||||||||||||||||
| 2023 | Plateletpheresis, crossmatched (unit) | Plateletpheresis, crossmatched (unit) | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2024 | Screening for historically antigen Negative blood per antigen | Screening for historically antigen Negative blood per antigen | Option 2 | 10/01/24 | 09/30/25 | 180 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 180 | EA | EACH | ||||||||||||||||||||||||||||||
| 2025 | Crossmatched Platelet Donor Recruitment | Crossmatched Platelet Donor Recruitment | Option 2 | 10/01/24 | 09/30/25 | 30 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 30 | EA | EACH | ||||||||||||||||||||||||||||||
| 2026 | Transportation charge for STAT orders | Transportation charge for STAT orders | Option 2 | 10/01/24 | 09/30/25 | 200 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 200 | EA | EACH | ||||||||||||||||||||||||||||||
| 2027 | Red cells, Washed | Red cells, Washed | Option 2 | 10/01/24 | 09/30/25 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 2028 | Volume-reduced cellular products | Volume-reduced cellular products | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2029 | DTT (Dithiothreitol) screen | DTT (Dithiothreitol) screen | Option 2 | 10/01/24 | 09/30/25 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 2030 | DTT (Dithiothreitol) panel | DTT (Dithiothreitol) panel | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2031 | RBC Genotype (HEA BeadChip Assay or similar) | RBC Genotype (HEA BeadChip Assay or similar) | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2032 | Drug study | Drug study | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2033 | Direct Antiglobulin Test | Direct Antiglobulin Test | Option 2 | 10/01/24 | 09/30/25 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 2034 | Adsorption Auto | Adsorption Auto | Option 2 | 10/01/24 | 09/30/25 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 2035 | Adsorption Allo | Adsorption Allo | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 2036 | Adsorption REST (cold auto) | Adsorption REST (cold auto) | Option 2 | 10/01/24 | 09/30/25 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 2037 | ABO/Rh grouping | ABO/Rh grouping | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2038 | Antibody Screen | Antibody Screen | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2039 | PLT Crossmatch (test) | PLT Crossmatch (test) | Option 2 | 10/01/24 | 09/30/25 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 2040 | Plateletpheresis, HLA matched | Plateletpheresis, HLA matched | Option 2 | 10/01/24 | 09/30/25 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 2041 | PLT Antibody screen | PLT Antibody screen | Option 2 | 10/01/24 | 09/30/25 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 2042 | HLA Antibody screen | HLA Antibody screen | Option 2 | 10/01/24 | 09/30/25 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 2043 | Patient HLA (A,B) typing for HLA PLT selection | Patient HLA (A,B) typing for HLA PLT selection | Option 2 | 10/01/24 | 09/30/25 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 2044 | HPA-1a Antigen screen | HPA-1a Antigen screen | Option 2 | 10/01/24 | 09/30/25 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 2045 | Molecular genotype (HPA) | Molecular genotype (HPA) | Option 2 | 10/01/24 | 09/30/25 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 2046 | SARS-CoV-2 Convalescent Plasma | SARS-CoV-2 Convalescent Plasma | Option 2 | 10/01/24 | 09/30/25 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3001 | Leukoc-poor RBC | Leukoc-poor RBC | Option 3 | 10/01/25 | 09/30/26 | 1400 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1400 | EA | EACH | ||||||||||||||||||||||||||||||
| 3002 | STAT off hours surcharge | STAT off hours surcharge | Option 3 | 10/01/25 | 09/30/26 | 40 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 40 | EA | EACH | ||||||||||||||||||||||||||||||
| 3003 | Red Cells, Irradiated | Red Cells, Irradiated | Option 3 | 10/01/25 | 09/30/26 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 3004 | Red Cells, Autologous | Red Cells, Autologous | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3005 | Red Cells, Thawed | Red Cells, Thawed | Option 3 | 10/01/25 | 09/30/26 | 6 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 6 | EA | EACH | ||||||||||||||||||||||||||||||
| 3006 | Red Cells, Directed | Red Cells, Directed | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3007 | Fresh Frozen Plasma | Fresh Frozen Plasma | Option 3 | 10/01/25 | 09/30/26 | 300 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 300 | EA | EACH | ||||||||||||||||||||||||||||||
| 3008 | Platelet, LVDS | Platelet, LVDS | Option 3 | 10/01/25 | 09/30/26 | 405 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 405 | EA | EACH | ||||||||||||||||||||||||||||||
| 3009 | PLATELET, PRT | PLATELET, PRT | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3010 | Pooled Cryo | Pooled Cryo | Option 3 | 10/01/25 | 09/30/26 | 70 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 70 | EA | EACH | ||||||||||||||||||||||||||||||
| 3011 | RhIg | RhIg | Option 3 | 10/01/25 | 09/30/26 | 2 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 2 | EA | EACH | ||||||||||||||||||||||||||||||
| 3012 | Screening for negative blood per antigen | Screening for negative blood per antigen | Option 3 | 10/01/25 | 09/30/26 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 3013 | IRRADIATE UNITS | IRRADIATE UNITS | Option 3 | 10/01/25 | 09/30/26 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 3014 | SCREENING FOR CMV NEGATIVE BLOOD | SCREENING FOR CMV NEGATIVE BLOOD | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3015 | Antibody Identification | Antibody Identification | Option 3 | 10/01/25 | 09/30/26 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 3016 | Enzyme Panel | Enzyme Panel | Option 3 | 10/01/25 | 09/30/26 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 3017 | Select Cell Panel | Select Cell Panel | Option 3 | 10/01/25 | 09/30/26 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 3018 | Absorption/Elution with Panel | Absorption/Elution with Panel | Option 3 | 10/01/25 | 09/30/26 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 3019 | Inhibition/Panel | Inhibition/Panel | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3020 | Chloroquine Treatment | Chloroquine Treatment | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3021 | Extended Phenotyping | Extended Phenotyping | Option 3 | 10/01/25 | 09/30/26 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 3022 | Phenotyping, Whole Blood or Red Cell Mass | Phenotyping, Whole Blood or Red Cell Mass | Option 3 | 10/01/25 | 09/30/26 | 28 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 28 | EA | EACH | ||||||||||||||||||||||||||||||
| 3023 | Plateletpheresis, crossmatched (unit) | Plateletpheresis, crossmatched (unit) | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3024 | Screening for historically antigen Negative blood per antigen | Screening for historically antigen Negative blood per antigen | Option 3 | 10/01/25 | 09/30/26 | 180 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 180 | EA | EACH | ||||||||||||||||||||||||||||||
| 3025 | Crossmatched Platelet Donor Recruitment | Crossmatched Platelet Donor Recruitment | Option 3 | 10/01/25 | 09/30/26 | 30 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 30 | EA | EACH | ||||||||||||||||||||||||||||||
| 3026 | Transportation charge for STAT orders | Transportation charge for STAT orders | Option 3 | 10/01/25 | 09/30/26 | 200 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 200 | EA | EACH | ||||||||||||||||||||||||||||||
| 3027 | Red cells, Washed | Red cells, Washed | Option 3 | 10/01/25 | 09/30/26 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 3028 | Volume-reduced cellular products | Volume-reduced cellular products | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3029 | DTT (Dithiothreitol) screen | DTT (Dithiothreitol) screen | Option 3 | 10/01/25 | 09/30/26 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 3030 | DTT (Dithiothreitol) panel | DTT (Dithiothreitol) panel | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3031 | RBC Genotype (HEA BeadChip Assay or similar) | RBC Genotype (HEA BeadChip Assay or similar) | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3032 | Drug study | Drug study | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3033 | Direct Antiglobulin Test | Direct Antiglobulin Test | Option 3 | 10/01/25 | 09/30/26 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 3034 | Adsorption Auto | Adsorption Auto | Option 3 | 10/01/25 | 09/30/26 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 3035 | Adsorption Allo | Adsorption Allo | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 3036 | Adsorption REST (cold auto) | Adsorption REST (cold auto) | Option 3 | 10/01/25 | 09/30/26 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 3037 | ABO/Rh grouping | ABO/Rh grouping | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3038 | Antibody Screen | Antibody Screen | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3039 | PLT Crossmatch (test) | PLT Crossmatch (test) | Option 3 | 10/01/25 | 09/30/26 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 3040 | Plateletpheresis, HLA matched | Plateletpheresis, HLA matched | Option 3 | 10/01/25 | 09/30/26 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 3041 | PLT Antibody screen | PLT Antibody screen | Option 3 | 10/01/25 | 09/30/26 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 3042 | HLA Antibody screen | HLA Antibody screen | Option 3 | 10/01/25 | 09/30/26 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 3043 | Patient HLA (A,B) typing for HLA PLT selection | Patient HLA (A,B) typing for HLA PLT selection | Option 3 | 10/01/25 | 09/30/26 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 3044 | HPA-1a Antigen screen | HPA-1a Antigen screen | Option 3 | 10/01/25 | 09/30/26 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 3045 | Molecular genotype (HPA) | Molecular genotype (HPA) | Option 3 | 10/01/25 | 09/30/26 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 3046 | SARS-CoV-2 Convalescent Plasma | SARS-CoV-2 Convalescent Plasma | Option 3 | 10/01/25 | 09/30/26 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4001 | Leukoc-poor RBC | Leukoc-poor RBC | Option 4 | 10/01/26 | 09/30/27 | 1400 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1400 | EA | EACH | ||||||||||||||||||||||||||||||
| 4002 | STAT off hours surcharge | STAT off hours surcharge | Option 4 | 10/01/26 | 09/30/27 | 40 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 40 | EA | EACH | ||||||||||||||||||||||||||||||
| 4003 | Red Cells, Irradiated | Red Cells, Irradiated | Option 4 | 10/01/26 | 09/30/27 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 4004 | Red Cells, Autologous | Red Cells, Autologous | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4005 | Red Cells, Thawed | Red Cells, Thawed | Option 4 | 10/01/26 | 09/30/27 | 6 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 6 | EA | EACH | ||||||||||||||||||||||||||||||
| 4006 | Red Cells, Directed | Red Cells, Directed | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4007 | Fresh Frozen Plasma | Fresh Frozen Plasma | Option 4 | 10/01/26 | 09/30/27 | 300 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 300 | EA | EACH | ||||||||||||||||||||||||||||||
| 4008 | Platelet, LVDS | Platelet, LVDS | Option 4 | 10/01/26 | 09/30/27 | 405 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 405 | EA | EACH | ||||||||||||||||||||||||||||||
| 4009 | PLATELET, PRT | PLATELET, PRT | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4010 | Pooled Cryo | Pooled Cryo | Option 4 | 10/01/26 | 09/30/27 | 70 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 70 | EA | EACH | ||||||||||||||||||||||||||||||
| 4011 | RhIg | RhIg | Option 4 | 10/01/26 | 09/30/27 | 2 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 2 | EA | EACH | ||||||||||||||||||||||||||||||
| 4012 | Screening for negative blood per antigen | Screening for negative blood per antigen | Option 4 | 10/01/26 | 09/30/27 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 4013 | IRRADIATE UNITS | IRRADIATE UNITS | Option 4 | 10/01/26 | 09/30/27 | 100 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 100 | EA | EACH | ||||||||||||||||||||||||||||||
| 4014 | SCREENING FOR CMV NEGATIVE BLOOD | SCREENING FOR CMV NEGATIVE BLOOD | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4015 | Antibody Identification | Antibody Identification | Option 4 | 10/01/26 | 09/30/27 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 4016 | Enzyme Panel | Enzyme Panel | Option 4 | 10/01/26 | 09/30/27 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 4017 | Select Cell Panel | Select Cell Panel | Option 4 | 10/01/26 | 09/30/27 | 20 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 20 | EA | EACH | ||||||||||||||||||||||||||||||
| 4018 | Absorption/Elution with Panel | Absorption/Elution with Panel | Option 4 | 10/01/26 | 09/30/27 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 4019 | Inhibition/Panel | Inhibition/Panel | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4020 | Chloroquine Treatment | Chloroquine Treatment | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4021 | Extended Phenotyping | Extended Phenotyping | Option 4 | 10/01/26 | 09/30/27 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 4022 | Phenotyping, Whole Blood or Red Cell Mass | Phenotyping, Whole Blood or Red Cell Mass | Option 4 | 10/01/26 | 09/30/27 | 28 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 28 | EA | EACH | ||||||||||||||||||||||||||||||
| 4023 | Plateletpheresis, crossmatched (unit) | Plateletpheresis, crossmatched (unit) | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4024 | Screening for historically antigen Negative blood per antigen | Screening for historically antigen Negative blood per antigen | Option 4 | 10/01/26 | 09/30/27 | 180 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 180 | EA | EACH | ||||||||||||||||||||||||||||||
| 4025 | Crossmatched Platelet Donor Recruitment | Crossmatched Platelet Donor Recruitment | Option 4 | 10/01/26 | 09/30/27 | 30 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 30 | EA | EACH | ||||||||||||||||||||||||||||||
| 4026 | Transportation charge for STAT orders | Transportation charge for STAT orders | Option 4 | 10/01/26 | 09/30/27 | 200 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 200 | EA | EACH | ||||||||||||||||||||||||||||||
| 4027 | Red cells, Washed | Red cells, Washed | Option 4 | 10/01/26 | 09/30/27 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 4028 | Volume-reduced cellular products | Volume-reduced cellular products | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4029 | DTT (Dithiothreitol) screen | DTT (Dithiothreitol) screen | Option 4 | 10/01/26 | 09/30/27 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 4030 | DTT (Dithiothreitol) panel | DTT (Dithiothreitol) panel | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4031 | RBC Genotype (HEA BeadChip Assay or similar) | RBC Genotype (HEA BeadChip Assay or similar) | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4032 | Drug study | Drug study | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4033 | Direct Antiglobulin Test | Direct Antiglobulin Test | Option 4 | 10/01/26 | 09/30/27 | 25 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 25 | EA | EACH | ||||||||||||||||||||||||||||||
| 4034 | Adsorption Auto | Adsorption Auto | Option 4 | 10/01/26 | 09/30/27 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 4035 | Adsorption Allo | Adsorption Allo | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH | ||||||||||||||||||||||||||||||
| 4036 | Adsorption REST (cold auto) | Adsorption REST (cold auto) | Option 4 | 10/01/26 | 09/30/27 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 4037 | ABO/Rh grouping | ABO/Rh grouping | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4038 | Antibody Screen | Antibody Screen | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4039 | PLT Crossmatch (test) | PLT Crossmatch (test) | Option 4 | 10/01/26 | 09/30/27 | 15 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 15 | EA | EACH | ||||||||||||||||||||||||||||||
| 4040 | Plateletpheresis, HLA matched | Plateletpheresis, HLA matched | Option 4 | 10/01/26 | 09/30/27 | 5 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 5 | EA | EACH | ||||||||||||||||||||||||||||||
| 4041 | PLT Antibody screen | PLT Antibody screen | Option 4 | 10/01/26 | 09/30/27 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 4042 | HLA Antibody screen | HLA Antibody screen | Option 4 | 10/01/26 | 09/30/27 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 4043 | Patient HLA (A,B) typing for HLA PLT selection | Patient HLA (A,B) typing for HLA PLT selection | Option 4 | 10/01/26 | 09/30/27 | 8 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 8 | EA | EACH | ||||||||||||||||||||||||||||||
| 4044 | HPA-1a Antigen screen | HPA-1a Antigen screen | Option 4 | 10/01/26 | 09/30/27 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 4045 | Molecular genotype (HPA) | Molecular genotype (HPA) | Option 4 | 10/01/26 | 09/30/27 | 1 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 1 | EA | EACH | ||||||||||||||||||||||||||||||
| 4046 | SARS-CoV-2 Convalescent Plasma | SARS-CoV-2 Convalescent Plasma | Option 4 | 10/01/26 | 09/30/27 | 10 | EA | 1 | Quantity | Priced | 0 | Percent | 0 | 621991 | 6505 | N/A | 10 | EA | EACH |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .